Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brenntag SE stock logo
BNTGY
Brenntag
$16.16
-0.3%
$17.06
$14.21
$18.72
$11.95B1.1920,971 shs12,481 shs
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
$29.90
$27.64
$23.07
$30.26
$13.53B1.07258 shsN/A
Halma plc stock logo
HLMAF
Halma
$27.45
$28.90
$21.55
$31.44
N/A1.154,802 shs562 shs
Persimmon Plc stock logo
PSMMY
Persimmon
$32.56
-0.9%
$33.78
$23.04
$38.60
$5.25B1.6811,805 shs10,289 shs
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$51.60
$51.60
$51.60
$51.98
N/A0.32N/AN/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brenntag SE stock logo
BNTGY
Brenntag
-0.31%+1.19%-4.09%-7.02%+1.06%
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
0.00%0.00%+11.44%+20.08%+6.94%
Halma plc stock logo
HLMAF
Halma
0.00%+0.72%-7.76%-2.49%-1.24%
Persimmon Plc stock logo
PSMMY
Persimmon
-0.91%+1.46%-2.19%-14.09%+0.63%
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
0.00%0.00%0.00%0.00%+26.07%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Brenntag SE stock logo
BNTGY
Brenntag
N/AN/AN/AN/AN/AN/AN/AN/A
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
N/AN/AN/AN/AN/AN/AN/AN/A
Halma plc stock logo
HLMAF
Halma
0.0719 of 5 stars
1.01.00.00.00.00.01.3
Persimmon Plc stock logo
PSMMY
Persimmon
2.8733 of 5 stars
0.04.01.70.02.20.03.1
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brenntag SE stock logo
BNTGY
Brenntag
1.50
ReduceN/AN/A
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
2.00
HoldN/AN/A
Halma plc stock logo
HLMAF
Halma
N/AN/A$32.2017.30% Upside
Persimmon Plc stock logo
PSMMY
Persimmon
2.00
HoldN/AN/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
2.00
HoldN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brenntag SE stock logo
BNTGY
Brenntag
$20.47B0.58$1.76 per share9.19$6.55 per share2.47
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
$6.35B2.13$2.07 per share14.43$4.77 per share6.27
Halma plc stock logo
HLMAF
Halma
$2.23BN/A$1.08 per share25.48$5.08 per shareN/A
Persimmon Plc stock logo
PSMMY
Persimmon
$3.45B1.51$6.24 per share5.22$26.64 per share1.22
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$1.95BN/A$3.06 per share16.86$7.90 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brenntag SE stock logo
BNTGY
Brenntag
$934.33M$0.9716.6615.39N/A3.90%15.01%6.27%N/A
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
$545.16MN/A0.0019.54N/AN/AN/AN/AN/A
Halma plc stock logo
HLMAF
Halma
$282.64MN/A0.0024.73N/AN/AN/AN/AN/A
Persimmon Plc stock logo
PSMMY
Persimmon
$317.60MN/A0.0011.590.94N/AN/AN/AN/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$329.08M$1.9326.7418.36N/A18.51%31.80%12.83%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Brenntag SE stock logo
BNTGY
Brenntag
$0.050.31%N/A5.15%N/A
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
N/AN/AN/AN/AN/A
Halma plc stock logo
HLMAF
Halma
N/AN/AN/AN/AN/A
Persimmon Plc stock logo
PSMMY
Persimmon
$0.892.73%N/AN/AN/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brenntag SE stock logo
BNTGY
Brenntag
N/A
1.65
1.16
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
1.04
1.67
N/A
Halma plc stock logo
HLMAF
Halma
0.40
2.68
1.69
Persimmon Plc stock logo
PSMMY
Persimmon
N/AN/AN/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
0.80
1.28
0.86

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Brenntag SE stock logo
BNTGY
Brenntag
17,500737.27 millionN/ANot Optionable
Bureau Veritas SA stock logo
BVRDF
Bureau Veritas
82,000452.37 millionN/ANot Optionable
Halma plc stock logo
HLMAF
Halma
8,000N/AN/ANot Optionable
Persimmon Plc stock logo
PSMMY
Persimmon
5,862159.84 million158.87 millionNot Optionable
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
4,369N/AN/ANot Optionable

BNTGY, HLMAF, PSMMY, BVRDF, and RCDTF Headlines

SourceHeadline
Borsa: Milano fiacca con Recordati e Saipem, vola StmBorsa: Milano fiacca con Recordati e Saipem, vola Stm
msn.com - April 24 at 2:06 PM
Cvc Capital Partners al lavoro sul ‘dossier’ RecordatiCvc Capital Partners al lavoro sul ‘dossier’ Recordati
businesspeople.it - April 24 at 9:06 AM
Recordati scende in Borsa, spunti da analisti e mosse CVCRecordati scende in Borsa, spunti da analisti e mosse CVC
teleborsa.it - April 24 at 9:06 AM
CVC explores options for Italys Recordati, Bloomberg News reportsCVC explores options for Italy's Recordati, Bloomberg News reports
msn.com - April 23 at 6:03 PM
CVC Explores Options for €11 Billion Drugmaker RecordatiCVC Explores Options for €11 Billion Drugmaker Recordati
finance.yahoo.com - April 23 at 6:03 PM
UPDATE 1-CVC explores options for Italys Recordati, Bloomberg News reportsUPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports
finance.yahoo.com - April 23 at 6:03 PM
Recordati, ricavi in aumento del 10,2% nel primo trimestreRecordati, ricavi in aumento del 10,2% nel primo trimestre
teleborsa.it - April 22 at 2:59 PM
Recordati: +10% ricavi I trim. a 607 mln, "forte inizio danno"Recordati: +10% ricavi I trim. a 607 mln, "forte inizio d'anno"
borsaitaliana.it - April 22 at 8:29 AM
Recordati, ok dei soci al bilancio e al dividendo. Landamento dei ricavi nel 1Q2024Recordati, ok dei soci al bilancio e al dividendo. L'andamento dei ricavi nel 1Q2024
soldionline.it - April 22 at 8:29 AM
Recordati, concluso il programma di buybackRecordati, concluso il programma di buyback
finanza.repubblica.it - April 11 at 6:02 PM
Recordati, azioni proprie all1,33% del capitale socialeRecordati, azioni proprie all'1,33% del capitale sociale
teleborsa.it - April 10 at 3:16 PM
Recordati in positivo dopo l’intervista al CEORecordati in positivo dopo l’intervista al CEO
trend-online.com - April 8 at 12:43 PM
Recordati, Investco detiene il 3,014%Recordati, Investco detiene il 3,014%
soldionline.it - March 22 at 6:51 AM
Azionario Italia: Recordati Dopo il Massimo Annuale Scende. OVS Resistenza a 3,25€Azionario Italia: Recordati Dopo il Massimo Annuale Scende. OVS Resistenza a 3,25€
fxempire.it - March 20 at 7:35 PM
Recordati, CdA approva bilancio 2023. Dividendo totale di 1,20 euroRecordati, CdA approva bilancio 2023. Dividendo totale di 1,20 euro
teleborsa.it - March 19 at 1:05 PM
Farmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunitàFarmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunità
msn.com - March 19 at 1:05 PM
Recordati: cda propone dividendo 1,20 per azione, di cui 0,57 gia pagati (RCO)Recordati: cda propone dividendo 1,20 per azione, di cui 0,57 gia' pagati (RCO)
borsa.corriere.it - March 19 at 8:05 AM
Recordati: positivo il superamento dei 53 euroRecordati: positivo il superamento dei 53 euro
milanofinanza.it - February 26 at 8:11 AM
Recordati ben intonato dopo i numeri 2023. Come è andata?Recordati ben intonato dopo i numeri 2023. Come è andata?
trend-online.com - February 25 at 10:26 AM
Le azioni Recordati non brillano dopo i conti, ma il futuro resta molto interessanteLe azioni Recordati non brillano dopo i conti, ma il futuro resta molto interessante
proiezionidiborsa.it - February 23 at 3:53 PM
Analisi Azionaria: STMicroelectronics Sotto Pressione, Recordati Verso nuovi MassimiAnalisi Azionaria: STMicroelectronics Sotto Pressione, Recordati Verso nuovi Massimi
fxempire.it - February 2 at 8:36 AM
Recordati, informativa sul buybackRecordati, informativa sul buyback
teleborsa.it - January 31 at 8:34 PM
Recordati: resistenza grafica a quota 51 euroRecordati: resistenza grafica a quota 51 euro
milanofinanza.it - January 30 at 8:47 AM
Recordati: il titolo allunga al rialzoRecordati: il titolo allunga al rialzo
milanofinanza.it - January 15 at 8:59 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Brenntag logo

Brenntag

OTCMKTS:BNTGY
Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber industries. The company was founded in 1874 and is based in Essen, Germany.
Bureau Veritas logo

Bureau Veritas

OTCMKTS:BVRDF
Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products. The company engages in inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its customers in relation to regulatory or self-imposed standards, as well as issues compliance reports. It also provides laboratory and on-site testing services for manufacturing and process industries; inspection services for products, services, assets, and installations, as well as various services designed to control quality, verify quantity, and meet regulatory requirements; and certification services for management systems, products, and people. The company serves automotive and transportation, building and infrastructure, chemicals, commodities and agriculture, consumer products and retail, food, marine and offshore, oil and gas, and power and utilities industries, as well as financial services and public sectors. It operates in approximately 140 countries through a network of 1,600 offices and laboratories. Bureau Veritas SA was founded in 1828 and is headquartered in Neuilly-sur-Seine, France.
Halma logo

Halma

OTCMKTS:HLMAF
Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire safety, fire detection and fire suppression; safe movement in public, commercial, and industrial spaces; elevator safety; communications in emergencies; control of access in potentially hazardous industrial and commercial environments; electrical safety; and the safe management of pipelines and storage assets solutions. This segment serves shops and restaurants, healthcare facilities, and offices and stadiums; industrial and logistics assets; public spaces and critical infrastructure; and aerospace, and rail and automotive markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring, water and waste water analysis and treatment, gas analysis and detection, and optical analysis systems. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; components, devices and systems that provide information and analytics to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
Persimmon logo

Persimmon

OTCMKTS:PSMMY
Persimmon Plc, together with its subsidiaries, operates as a house builder in the United Kingdom. The company offers family housing under the Persimmon Homes brand name; housing under the Charles Church brand name; and social housing under the Westbury Partnerships brand name. It also provides broadband services under the FibreNest brand; and timber frame, insulated wall panels, and roof cassettes under the brand Space4. Further, it offers concrete bricks and roof tile. Persimmon Plc was founded in 1972 and is headquartered in York, the United Kingdom.
Recordati Industria Chimica e Farmaceutica logo

Recordati Industria Chimica e Farmaceutica

OTCMKTS:RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.